enow.com Web Search

Search results

    74.00-2.000 (-2.63%)

    at Thu, May 30, 2024, 11:00AM EDT - U.S. markets close in 15 minutes

    Delayed Quote

    • Open 78.00
    • High 78.00
    • Low 73.00
    • Prev. Close 76.00
    • 52 Wk. High 110.00
    • 52 Wk. Low 46.00
    • P/E N/A
    • Mkt. Cap 1.04B
  1. Results from the WOW.Com Content Network
  2. United States passport - Wikipedia

    en.wikipedia.org/wiki/United_States_passport

    Visa requirements for United States citizens are administrative entry restrictions by the authorities of other states placed on citizens of the United States. As of July 2023, holders of a United States passport can visit 184 countries and territories without a visa or with a visa on arrival, ranking it eighth in terms of travel freedom ...

  3. U visa - Wikipedia

    en.wikipedia.org/wiki/U_visa

    U visa. The U visa is a United States nonimmigrant visa which is set aside for victims of crimes (and their immediate family members) who have suffered substantial mental or physical abuse while in the U.S. and who are willing to assist law enforcement and government officials in the investigation or prosecution of the criminal activity. [1]

  4. Canada permanent resident card - Wikipedia

    en.wikipedia.org/wiki/Canada_permanent_resident_card

    The Permanent Resident card ( French: carte de résident permanent) also known colloquially as the PR Card or the Maple Leaf card, is an identification document and a travel document for permanent residents of Canada. [1] It is one of the methods by which Canadian permanent residents can prove their status and is, along with the permanent ...

  5. Visa Inc. - Wikipedia

    en.wikipedia.org/wiki/Visa_Inc.

    Visa Inc. ( / ˈviːzə, ˈviːsə /; stylized as VISA) is an American multinational payment card services corporation headquartered in San Francisco, California. [1] [4] It facilitates electronic funds transfers throughout the world, most commonly through Visa-branded credit cards, debit cards and prepaid cards. [5]

  6. Averting Loss of Life and Injury by Expediting SIVs Act of ...

    en.wikipedia.org/wiki/Averting_Loss_of_Life_and...

    The Averting Loss of Life and Injury by Expediting SIVs Act (ALLIES) Act is a bipartisan piece of legislation that would remove or revise some statutory requirements in the Special Immigrant Visa (SIV) process and designed to expedite the SIV process and increase the total number of visas available by several thousand.

  7. False billing - Wikipedia

    en.wikipedia.org/wiki/False_billing

    False billing is a fraudulent act of invoicing or otherwise requesting funds from an individual or firm without showing obligation to pay. Such notices are, for example, often sent to owners of domain names, purporting to be legitimate renewal notices, although not originating from the owner's own registrar .

  8. Purple - Wikipedia

    en.wikipedia.org/wiki/Purple

    Purple is a color similar in appearance to violet light. In the RYB color model historically used in the arts, purple is a secondary color created by combining red and blue pigments. In the CMYK color model used in modern printing, purple is made by combining magenta pigment with either cyan pigment, black pigment, or both.

  9. Loopy Godinez - Wikipedia

    en.wikipedia.org/wiki/Loopy_Godinez

    Losses. 4. By decision. 4. Mixed martial arts record from Sherdog. Lupita " Loopy " Godínez (born September 6, 1993) is a Mexican-Canadian professional mixed martial artist, she currently competes in the Strawweight division of the Ultimate Fighting Championship. As of January 23, 2024, she is #10 in the UFC women's strawweight rankings.

  10. RB VCARB 01 - Wikipedia

    en.wikipedia.org/wiki/RB_VCARB_01

    22. Yuki Tsunoda. The RB VCARB 01 is a Formula One car constructed by RB Formula One Team for the 2024 Formula One World Championship. The car is currently being driven by Daniel Ricciardo and Yuki Tsunoda.

  11. Vancomycin-resistant Staphylococcus aureus - Wikipedia

    en.wikipedia.org/wiki/Vancomycin-resistant...

    Vancomycin-intermediate S. aureus (VISA) ( / ˈviːsə / or / viːaɪɛseɪ /) was first identified in Japan in 1996 [11] and has since been found in hospitals elsewhere in Asia, as well as in the United Kingdom, France, the U.S., and Brazil. It is also termed GISA (glycopeptide-intermediate Staphylococcus aureus ), indicating resistance to all ...